On Monday, uniQure N.V. (NASDAQ: QURE) opened lower -3.09% from the last session, before settling in for the closing price of $4.53. Price fluctuations for QURE have ranged from $4.35 to $22.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 302.35%. Company’s average yearly earnings per share was noted 33.53% at the time writing. With a float of $43.18 million, this company’s outstanding shares have now reached $47.83 million.
The extent of productivity of a business whose workforce counts for 480 workers is very important to gauge.
uniQure N.V. (QURE) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of uniQure N.V. is 11.05%, while institutional ownership is 77.16%. The most recent insider transaction that took place on Feb 26 ’24, was worth 177,190. In this transaction CEO, Managing Director of this company sold 27,904 shares at a rate of $6.35, taking the stock ownership to the 440,839 shares. Before that another transaction happened on Feb 26 ’24, when Company’s Chief Financial Officer sold 15,906 for $6.38, making the entire transaction worth $101,480. This insider now owns 116,948 shares in total.
uniQure N.V. (QURE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 33.53% per share during the next fiscal year.
uniQure N.V. (NASDAQ: QURE) Trading Performance Indicators
Check out the current performance indicators for uniQure N.V. (QURE). In the past quarter, the stock posted a quick ratio of 8.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.47, a number that is poised to hit -1.28 in the next quarter and is forecasted to reach -3.86 in one year’s time.
Technical Analysis of uniQure N.V. (QURE)
The latest stats from [uniQure N.V., QURE] show that its last 5-days average volume of 0.56 million was inferior to 0.96 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 25.08%. Additionally, its Average True Range was 0.24.
During the past 100 days, uniQure N.V.’s (QURE) raw stochastic average was set at 0.93%, which indicates a significant decrease from 4.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.00% in the past 14 days, which was lower than the 69.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.25, while its 200-day Moving Average is $6.72. Now, the first resistance to watch is $4.61. This is followed by the second major resistance level at $4.83. The third major resistance level sits at $4.95. If the price goes on to break the first support level at $4.27, it is likely to go to the next support level at $4.15. The third support level lies at $3.93 if the price breaches the second support level.
uniQure N.V. (NASDAQ: QURE) Key Stats
There are currently 47,838K shares outstanding in the company with a market cap of 213.09 million. Presently, the company’s annual sales total 15,840 K according to its annual income of -308,480 K. Last quarter, the company’s sales amounted to 6,690 K and its income totaled -73,210 K.
